菌株的多样性推动了对结核结合疗法的异质反应
Michelle H Yoon1,2, Peter H Culviner3, Mariana Pereira Moraes1,4
1Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, USA.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
结核菌菌菌株多样性影响药物反应. 根据药物易感性选择临床前菌株,而不仅仅是基因,更好地反映了组合疗法的临床结果.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 基因组学就是基因组学.
背景情况:
- 在Mycobacterium tuberculosis (Mtb) 中的菌株多样性会影响临床结果.
- 了解临床分离的药物敏感性表型至关重要.
- 关于不同Mtb菌株药物反应模式的知识有限.
研究的目的:
- 在基因学上多样化的Mtb临床隔离物中识别药物反应模式.
- 评估单药和组合疗法的表型反应.
- 了解菌株变异如何影响药物疗效.
主要方法:
- 选择了13种不同的Mtb临床菌株和一个参考菌株.
- 测试了10种单抗,双抗和三抗组合的抗生素.
- 在使用正常化增长率抑制 (GRmax) 的标准和富胆固醇介质中评估反应.
主要成果:
- Mtb菌株在65种组合和两种疾病中显示出不同的药物反应表型.
- 有效的药物对因菌株和代谢环境而有所不同.
- 菌株药物敏感性与组合治疗敏感性相关.
- 遗传关系,而不仅仅是距离,推动了药物反应的变化.
结论:
- 临床前研究应根据药物反应表型选择Mtb菌株,而不仅仅是基因多样性.
- 组合疗法的有效性取决于感染菌株和代谢利基.
- 了解特定菌株的药物反应是优化治疗策略的关键.
相关概念视频
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis I
811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III
901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
901
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K


